医脉通(02192)发布中期业绩 股东应占溢利1.55亿元 同比增加5.9%

Core Viewpoint - The company, Yimaitong (02192), reported a significant increase in revenue and profit for the six months ending June 30, 2025, indicating strong financial performance and growth potential in the healthcare sector [1]. Financial Performance - The company achieved a revenue of 312 million RMB, representing a year-on-year increase of 28.2% [1]. - The profit attributable to shareholders was 155 million RMB, which is a 5.9% increase compared to the previous year [1]. - The basic earnings per share were reported at 21.2 cents [1].